Alight, Inc. / Delaware (ALIT): Nasdaq/NYSE listing notice — Alight receives NYSE non-compliance notice for average closing price below $1.00

Alight, Inc. / Delaware

NYSE notified Alight on March 24, 2026 that average closing price was below $1.00 over 30 trading days ending March 20.
Company has a six-month cure period to regain compliance; considering reverse stock split subject to stockholder approval.
Common stock continues trading on NYSE under symbol ALIT during the cure period with no immediate impact on listing.
No anticipated impact on business operations or SEC reporting requirements.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Alight, Inc. / Delaware received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

March 24, 2026 , Alight, Inc. (the “Company” or “Alight”) received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”), as the average closing price of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), was less than $1.00 per share over a consecutive 30 trading-day period ending March 20, 2026. The Notice does not affect the Company’s ongoing business operations or its U.S. Securities

View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Alight, Inc. / Delaware filing history →

Source: SEC EDGAR

accession 0001628280-26-021571

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.